| Health / Medical Topics |
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
A cancer vaccine consisting of a proprietary, recombinant modified vaccinia Ankara (MVA) viral vector encoding an epitope of human epidermal growth factor receptor 2 (HER2) with potential antineoplastic activity. Upon administration, modified vaccinia Ankara (Bavarian Nordic)-HER2 vaccine may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte responses against HER2-expressing tumor cells, resulting in tumor cell lysis. HER2, also known as ErbB-2, is a tyrosine kinase growth factor receptor and a member of the epidermal growth factor receptor family; it plays a significant role in the pathogenesis of some breast cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A solid, semi-solid, solution or suspension exhibiting an altered inherent rate of release of active and/or inert ingredient(s).
A standardized questionnaire originally developed by John Rankin in 1957, and later modified by Van Swieten et al in 1988, which is…
A six point scale that qualifies a person's physical abilities following a cerebrovascular accident. It is commonly used as a primary endpoint…
Surgery to remove most, but not all, of the vulva (the external female genital organs, including the clitoris, vaginal lips, and the…
A surgical procedure in which all the ipsilateral cervical lymph node groups of the neck are removed but the internal jugular vein,…
Surgery for breast cancer in which the breast, most or all of the lymph nodes under the arm, and the lining over…
